NATHAN BLAKE JOHN

Allopathic & Osteopathic Physicians|Family Medicine EDMOND, OK NPI 1972036168

General Payments — all program years on this page

$1,621.19

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 75
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $917.58 across 41 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $917.5841

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $703.6134
2024 $917.5841

Records — PY2024 (41)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096647680 Novo Nordisk Inc $15.24 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096954968 Novo Nordisk Inc $16.89 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103999355 ABBVIE INC. $17.16 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103999357 ABBVIE INC. $31.07 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103999359 ABBVIE INC. $16.89 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103999361 ABBVIE INC. $13.57 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105662052 AstraZeneca Pharmaceuticals LP $13.99 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105720054 AstraZeneca Pharmaceuticals LP $18.34 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110769385 Eisai Inc. $27.79 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114430732 Exact Sciences Corporation $17.57 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115768050 Amgen Inc. $21.70 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116269751 GlaxoSmithKline, LLC. $16.73 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116575894 GlaxoSmithKline, LLC. $14.87 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116806238 Insulet Corporation $15.68 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117589425 Amgen Inc. $13.54 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117589427 Amgen Inc. $14.12 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117774473 Corcept Therapeutics $25.32 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117774499 Corcept Therapeutics $19.17 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117774519 Corcept Therapeutics $17.43 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117774529 Corcept Therapeutics $17.14 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117774567 Corcept Therapeutics $15.62 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118255166 Boehringer Ingelheim Pharmaceuticals, Inc. $20.54 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118255168 Boehringer Ingelheim Pharmaceuticals, Inc. $27.21 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125363266 Abbott Laboratories $18.50 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125363268 Abbott Laboratories $148.52 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127038921 Kyowa Kirin, Inc. $19.44 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127038923 Kyowa Kirin, Inc. $15.59 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130782118 Nevro Corp. $26.03 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135236521 Lilly USA, LLC $16.86 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135236525 Lilly USA, LLC $13.72 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135238710 Lilly USA, LLC $14.99 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139366793 Astellas Pharma US Inc $26.01 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141984937 Merck Sharp & Dohme LLC $16.27 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141985971 Merck Sharp & Dohme LLC $17.05 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146465423 Antares Pharma, Inc. $17.49 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148307998 Axsome Therapeutics, Inc. $20.88 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148308000 Axsome Therapeutics, Inc. $24.23 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148308002 Axsome Therapeutics, Inc. $25.30 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150240398 JAZZ PHARMACEUTICALS INC. $37.16 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153453745 Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.64 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153670386 Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.32 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.